Merck's rotavirus vaccine approved by FDA

02/4/2006 | San Francisco Chronicle

The FDA approved Merck's RotaTeq vaccine against rotavirus, a virus that affects most young children and often is fatal in developing countries. In response to problems with an earlier vaccine, Merck and competitor GlaxoSmithKline conducted trials to ensure their vaccines do not cause dangerous obstructions of the intestine.

View Full Article in:

San Francisco Chronicle

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA